The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Open accessAbstract
Glioblastoma (GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF (also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low-grade disease that classically possesses PDGF and TP53 events. Here we show that concomitant central nervous system (CNS)-specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute-onset high-grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells (NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/progenitor cell differentiation, self-renewal and tumorigenic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although TP53 mutations are oncogenic in GBM, other genes, such as PTEN must also be mutated to drive GBM progression [28].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, the chronic cellular damage that leads to liver cirrhosis results in shortened telomeres, anaphase bridges and a dramatically increased risk of liver cancer (131-134).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Self-citationErratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Self-citationClarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 759
Pan, Z., Zhang, M., Zhang, F., Pan, H., Li, Y., Shao, Y., Yuan, X. T., Wang, J., & Chen, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010482 · Cited by 11
Kim, J., She, C., Potez, M., Huang, P. C., Wu, Q., Prager, B. C., Qiu, Z., Bao, S., Rich, J. N., & Liu, J. K. (2021) · Stem Cells · doi:10.1002/stem.3355 · Cited by 11
PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer
Allen, J., Wang, J., Zolotarskaya, O. Y., Sule, A. D., Mohammad, S., Arslan, S., Wynne, K. J., Yang, H., & Valerie, K. C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.003 · Cited by 11
Hypoxia, Gene Expression, and Metastasis
Razorenova, O. V., & Giaccia, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_3 · Cited by 11
Zhao, F., Zeng, J., Chen, C., Zhao, X., Zhang, T., THOMAS, G. V., Sears, R. C., Alumkal, J. J., Moran, A. E., Mills, G. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.18.629070 · Cited by 12
Figg, J., Chen, D., Font, L. F., Flores, C., & Jin, D. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae131 · Cited by 11
Fuentes-Fayos, A. C., G-García, M. E., Pérez‐Gómez, J. M., Peel, A., Blanco-Acevedo, C., Solivera, J., Ibáñez‐Costa, A., Gahete, M. D., Castano, J. P., & Luque, R. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031143 · Cited by 10
Boot, J. R., Rosser, G., Kancheva, D., Vinel, C., Lim, Y. M., Pomella, N., Zhang, X., Guglielmi, L., Sheer, D., Barnes, M. R., et al. (2022) · eLife · doi:10.7554/elife.77335 · Cited by 10
Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development
Daks, A. A., Parfenyev, S. E., Shuvalov, O. Y., Fedorova, O., Nazarov, A., Melino, G., & Barlev, N. A. (2024) · Biology Direct · doi:10.1186/s13062-024-00484-z · Cited by 10
Cryopreservation of cancer-initiating cells derived from glioblastoma
Tang, C. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s181 · Cited by 10
Otani, Y., Ishida, J., Kurozumi, K., Oka, T., Shimizu, T., Tomita, Y., Hattori, Y., Uneda, A., Matsumoto, Y., Michiue, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07745-0 · Cited by 13
Bioinformatical analysis of gene expression signatures of different glioma subtypes
Wang, R., Wei, J., Li, Z., Tian, Y., & Du, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.7660 · Cited by 10
Thome, I., Lacle, R., Voß, A., Bortolussi, G., Pantazis, G., Schmidt, A., Conrad, C., Jacob, R., Timmesfeld, N., Bartsch, J. W., et al. (2020) · Cancers · doi:10.3390/cancers12092456 · Cited by 11
Involvement of the Catecholamine Pathway in Glioblastoma Development
Krabóth, Z., Kajtár, B., Gálik, B., Gyenesei, A., Miseta, A., & Kálmán, B. (2021) · Cells · doi:10.3390/cells10030549 · Cited by 12
Wu, J., Li, X., Liang, J. Y., Fang, D., Yang, Z.-J., Wei, J., & Chen, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.940462 · Cited by 10
Ouyang, Y., Song, Y., & Lu, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028098 · Cited by 10
Maintenance of Critical Properties of Brain Tumor Stem-like Cells After Cryopreservation
Mao, X., Guo, G., Wang, P., Zhang, X., Xue, X., Zhang, W., Fei, Z., Jiang, X., & Yan, M. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9505-0 · Cited by 10
Stanniocalcin 1 is a prognostic biomarker in glioma
Luo, W., Chen, D., Wang, H., & Hu, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11792 · Cited by 10
The Adolescent and Young Adult with Cancer: State of the Art—Brain Tumor
Epelman, S. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0329-1 · Cited by 10
Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma
Husain, N., Malhan, P., Bhalla, S., Gupta, R., & Husain, M. (2010) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.59177 · Cited by 9
Kumar, P., Naumann, U., Aigner, L., Wischhusen, J., Beier, C. P., & Beier, D. (2015) · PubMed Central · Cited by 9
Staden, R. S., Gheorghe, S. S., Ilie‐Mihai, R., & Bădulescu, M. (2021) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/abeea2 · Cited by 9
Chen, Z., Zhang, W., Yan, Z., & Zhang, M. (2022) · Cancer Medicine · doi:10.1002/cam4.4913 · Cited by 9
Lozinski, M., Lumbers, E. R., Bowden, N. A., Martin, J. H., Fay, M. F., Pringle, K. G., & Tooney, P. A. (2024) · Cells · doi:10.3390/cells13070634 · Cited by 9
Overexpression Models: Lentiviral Modeling of Brain Cancer
Friedmann‐Morvinski, D., & Singer, O. (2013) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo110271 · Cited by 9
Isolation, cultivation and identification of brain glioma stem cells by magnetic bead sorting.
Zhou, X., Zheng, C., Shi, Q., Li, X., Shen, Z., & Yu, R. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.13.004 · Cited by 9
Upregulation of DNA Metabolism-Related Genes Contributes to Radioresistance of Glioblastoma
Wang, C., Zheng, W., Yao, D., Chen, Q., Zhu, L., Zhang, J., Pan, Y., Zhang, J., & Shao, C. (2019) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2018.251 · Cited by 9
Organ-specific regulation of CHD1 by acute PTEN and p53 loss in mice
Rahmy, S., Cheng, X., Wang, M., Feng, H., Qiu, W., Zhao, R., & Lü, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.136 · Cited by 9
Tumor Microenvironment — Perivascular and Perinecrotic Niches
Schiffer, D., Mellai, M., Annovazzi, L., Casalone, C., & Cassoni, P. (2015) · InTech eBooks · doi:10.5772/58962 · Cited by 9
The Side Story of Stem-like Glioma Cells
Persson, A. I., & Weiss, W. A. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.02.004 · Cited by 9
Brain and testicular tumors in mice with progenitor cells lacking BAX and BAK
Katz, S. G., Fisher, J. K., Correll, M., Bronson, R. T., Ligon, K. L., & Walensky, L. D. (2012) · Oncogene · doi:10.1038/onc.2012.421 · Cited by 9
Self-citationLin, C., Wang, M. H., Qin, Y., Mao, F., Xie, B., & Zhong, X. Y. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9900-x · Cited by 9
Role of Btg2 in the Progression of a PDGF-Induced Oligodendroglioma Model
Appolloni, I., Curreli, S., Caviglia, S., Barilari, M., Gambini, E., Pagano, A., & Malatesta, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131114667 · Cited by 9
Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma
Lopes, M., de Castro, J. V., Pojo, M., Gonçalves, C. S., Martins, E. P., Coimbra, B., Sotiropoulos, I., Sousa, N., Rodrigues, A. J., & Costa, B. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856210 · Cited by 8
Huang, L.-C., McKeown, C. R., He, H., Ta, A. C., & Cline, H. T. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316542121 · Cited by 8
Shen, X., Tan, J., Liu, R., Zhu, G., Rooper, L. M., & Xing, M. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13701 · Cited by 8
The subventricular zone structure, function and implications for neurological disease
Li, K., Zheng, Y., Cai, S., Fan, Z., Yang, J., Liu, Y., Liang, S., Song, M., Du, S., & Qi, L. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101398 · Cited by 9
Haaland, I., Hjelle, S. M., Reikvam, H., Sulen, A., Ryningen, A., McCormack, E., Bruserud, Ø., & Gjertsen, B. T. (2021) · Cells · doi:10.3390/cells10040833 · Cited by 9
The concept of radiation-enhanced stem cell differentiation
Mieloch, A. A., & Suchorska, W. M. (2015) · Radiology and Oncology · doi:10.1515/raon-2015-0022 · Cited by 8
Stem cells in cancer therapy: From their role in pathogenesis to their use as therapeutic agents
Aimola, P., Desiderio, V., Graziano, A., & Claudio, P. P. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.3.1489979 · Cited by 8
Chen, Q., Jiao, D., Wu, Y.-Q., Wang, L., Hu, H., Song, J., Yan, J., & Wu, L. (2013) · Molecular BioSystems · doi:10.1039/c3mb70288j · Cited by 8
1.4.3 The vector meson nonet (1- states)
Castro-Melchor, M., Le, H., & Hu, W. (2005) · Springer eBooks · doi:10.1007/10201111_6 · Cited by 8
Kaye, A. H., & Morokoff, A. P. (2014) · Neurosurgery · doi:10.1227/neu.0000000000000388 · Cited by 8
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
Kwon, N. S., Kim, D., & Yun, H. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s138912 · Cited by 8
Richard, S. A., & Kuugbee, E. D. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/4907167 · Cited by 8
Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro
Bryukhovetskiy, I., Mischenko, P., Толок, Е. В., Zaitsev, S., Khotimchenko, Y. S., & Bryukhovetskiy, A. S. (2015) · Oncology Letters · doi:10.3892/ol.2015.2952 · Cited by 8
DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line
Toda, Y., YOSHIMURA, R., ITAHARA, M., Imai, Y., Yamada, K., UNO, T., Nakata, S., Hosogi, S., Takata, K., & Ashihara, E. (2019) · Anticancer Research · doi:10.21873/anticanres.13803 · Cited by 8
Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches
Ribeiro, A., Fote, G., Himstead, A. S., Zheng, M., Elliott, E., Smith, S. M., Lou, J. J., & Yuen, C. (2025) · Biomedicines · doi:10.3390/biomedicines13081963 · Cited by 7
Mejía-Hernández, J. O., Keam, S. P., Saleh, R., Muntz, F., Fox, S. B., Byrne, D. J., Kogan, A., Pang, L., Huynh, J., Litchfield, C., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05211-y · Cited by 7
Pre-Clinical Models for CAR T-Cell Therapy for Glioma
Vandecandelaere, G., Ramapriyan, R., Gaffey, M., Richardson, L. G., Steuart, S. J., Tazhibi, M., Kalaw, A., Grewal, E. P., Sun, J., Curry, W. T., et al. (2024) · Cells · doi:10.3390/cells13171480 · Cited by 8
Kim, M. R., Bashir, K. M. I., Lee, J., Ku, M.-U., Kim, J. W., Kim, K.-Y., Shin, S. K., Hong, E.-J., Ku, S., & Choi, J. (2023) · Applied Sciences · doi:10.3390/app13169342 · Cited by 7
Tumor suppressive pathways in the control of neurogenesis
Bartesaghi, S., & Salomoni, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1063-9 · Cited by 8
Luo, X., Tu, T., Zhong, Y., Xu, S., Chen, X., Chen, L., & Yang, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.607989 · Cited by 7
Momeny, M., Arsiola, T., & Westermarck, J. K. (2021) · Biochemical Journal · doi:10.1042/bcj20210254 · Cited by 6
Bibliometric analysis of PTEN in neurodevelopment and neurodegeneration
Zhang, Y., Tan, Y.-T., Wang, M., Li, L., Huang, J.-F., & Wang, S. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1390324 · Cited by 6
Sharif, S. A. I., Harman, N., Hydock, D. S., & Olson, T. P. (2024) · World Academy of Sciences Journal · doi:10.3892/wasj.2024.256 · Cited by 6
Roy, S. A. B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i14.1579 · Cited by 6
Multimodal spatially resolved near-field scattering and absorption spectroscopy
Ostertag, E., Merz, T., & Kessler, R. W. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.909086 · Cited by 6
Spence, T., Nguyen, J., Bouffet, É., & Huang, A. (2010) · Springer eBooks · doi:10.1007/978-94-007-0298-1_15 · Cited by 6
Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis
Ji, P., Zhou, X., Liu, Q., Fuller, G. N., Phillips, L. M., & Zhang, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8080 · Cited by 6
The role of the PIK3CA gene in the development and aging of the brain
Xie, S.-Z., Ni, J., Guo, H., Luu, V., Wang, Y., Zhao, J. J., & Roberts, T. (2021) · Scientific Reports · doi:10.1038/s41598-020-79416-6 · Cited by 6
Self-citationCedeno‐Laurent, F., & Trujillo, J. R. (2011) · Microbiology Research · doi:10.4081/mr.2011.e11 · Cited by 6
Radke, J., Bortolussi, G., & Pagenstecher, A. (2013) · PLoS ONE · doi:10.1371/annotation/562d2594-464f-49f1-90ef-f78cafcd3956 · Cited by 6
Bhatia, T. N., Ganta, S., Meselhe, M., Sojka, C., Martija, A. A., Nieland, L., Rufen-Blanchette, U., Sing, A., King, A. T., Hub, B. O., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.10.15.682580 · Cited by 6
Wang, Z., Miu, K.-K., Chan, S.-W., Ou, F., Law, P. W. N., & Chan, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.956604 · Cited by 5
Kim, M., Lee, J., Ku, M.-U., Kim, K.-Y., Shin, S. K., Hong, E.-J., Ku, S., & Choi, J. (2023) · Applied Sciences · doi:10.3390/app13179578 · Cited by 5
Liu, H., Pan, Z., Lin, X., Chen, L., Yang, Q., Zhang, W., Dai, L., Zhang, Y., Li, W., Chen, Y., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18352 · Cited by 5
Comprehensive analysis reveals PLK3 as a promising immune target and prognostic indicator in glioma
QIAN, A., Wang, X., Huo, G., CHEN, S., Gong, R., Zhu, T., Zhao, C., Lu, F., & Qiao, L. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.050794 · Cited by 6
Rodent models of tumours of the central nervous system
Brandner, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13729 · Cited by 5
Schoof, M., Zheng, T., Sill, M., Imle, R., Cais, A., Altendorf, L., Fürst, A., Hofmann, N., Ernst, K., Vonficht, D., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02419-4 · Cited by 5
Biobanking: An Important Resource for Precision Medicine in Glioblastoma
Tan, M. S. Y., Sandanaraj, E., Tang, C., & Ang, B. T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-45457-3_4 · Cited by 5
Afshari, A. R., Sanati, M., Aminyavari, S., Keshavarzi, Z., Ahmadi, S. S., Oroojalian, F., Karav, S., & Sahebkar, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01666-5 · Cited by 6
Glioma Models: New GEMMs Add “Class” with Genomic and Expression Correlations
Maire, C. L., & Ligon, K. L. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.018 · Cited by 5
Self-citationTumor stem cells from glioblastoma multiforme
Никифорова, З. Н., Kudryavtsev, I. A., Arnotskaya, N. E., Bryukhovetskiy, I., & Шевченко, В. Е. (2016) · Advances in molecular oncology · doi:10.17650/2313-805x.2016.3.2.26-33 · Cited by 5
Enhanced cued fear memory following post-training whole body irradiation of 3-month-old mice
Olsen, R. H. J., Weber, S. J., Akinyeke, T. O., & Raber, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.11.031 · Cited by 6
Gargini, R., Segura‐Collar, B., Garranzo‐Asensio, M., Hortigüela, R., Iglesias-Hernández, P., Lobato-Alonso, D., Moreno-Raja, M., Esteban-Martín, S., Sepúlveda-Sánchez, J. M., Nevola, L., et al. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01176-6 · Cited by 5
Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review
Sarmiento, B. E., Callegari, S., Ghotme, K. A., & Akle, V. (2022) · Cells · doi:10.3390/cells11071204 · Cited by 5
Hayati, N., Tabriz, H. M., Nazar, E., & Gorji, R. (2021) · Romanian Journal of Neurology · doi:10.37897/rjn.2021.4.7 · Cited by 5
Ma, S., Wang, F., Wang, N., Jin, J., Ba, Y., Ji, H., Du, J., & Hu, S. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.886913 · Cited by 5
Valdez, M. J. M., Lu, V. M., Kim, E., Rivas, S. R., Govindarajan, V., Ivan, M. E., Komotar, R. J., Nath, A., Heiss, J. D., & Shah, A. H. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04095-4 · Cited by 5
Stemness Activity Underlying Whole Brain Regeneration in a Basal Chordate
Gordon, T., Zaquin, T., Kowarsky, M., Voskoboynik, Y., Hendin, N., Wurtzel, O., Caicci, F., Manni, L., Voskoboynik, A., & Shenkar, N. (2022) · Cells · doi:10.3390/cells11233727 · Cited by 5
The multifaceted role of quaking protein in neuropsychiatric disorders and tumor progression
Guo, Z., Liu, B., Wei, Y. J., Wang, H., Zhang, Q., & Hong, X. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1341114 · Cited by 5
Deciphering the topological landscape of glioma using a network theory framework
Yao, M.-C., Su, Y., Xiong, R., Zhang, X., Zhu, X., Chen, Y.-C., & Ao, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-77856-y · Cited by 4
Emerging Concepts in Neuro-Oncology
Sciuscio, D., & Hegi, M. E. (2012) · Springer eBooks · doi:10.1007/978-0-85729-458-6 · Cited by 5
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth
Xiao, H., Zhu, H., Bögler, O., Mónica, F. Z., Kots, A. Y., Murad, F., & Bian, K. (2023) · Cancers · doi:10.3390/cancers15051567 · Cited by 4
Taking advantage of neural development to treat glioblastoma
Zhang, Z., & Lin, C.-C. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12655 · Cited by 4
Guerrieri, R. A., Fischer, G. M., Kircher, D. A., Joon, A. Y., Cortez, J., Grossmann, A. H., Hudgens, C. W., Ledesma, D. A., Lazcano, R., Onana, C. Y. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.23.633049 · Cited by 4
Gu, W., Wang, X., Solmonson, A., Cai, L., Xiao, Y., Tasdogan, A., Franklin, J., Zhang, Y., Zhang, H., Westfall, A. K., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci197010 · Cited by 3
Stem Cells in Brain Tumour Development and Therapy- Two-Sides of the Same Coin
Lee, C., Dunn, S. E., & Yip, S. S. F. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013159 · Cited by 3
Modeling genetic mosaicism of the mammalian target of rapamycin pathway in the cerebral cortex
Feliciano, D. M. (2023) · Frontiers in Mammal Science · doi:10.3389/fmamm.2023.1231778 · Cited by 3
Deciphering the role of transcription factors in glioblastoma cancer stem cells
Li, K., Li, H., He, A., Zhang, G., Jin, Y., Cai, J., Ye, C., Qi, L., & Liu, Y. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024061 · Cited by 3
Liu, J., Luo, Q., Zhao, H., Yang, M., Yang, J., Wang, Y., Zhao, M., Mao, J., Chen, J., Guo, B., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.11.016 · Cited by 3
Self-citationRETRACTED: Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
Xie, L., & Wang, F. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1638060 · Cited by 5
RetractedThe Impact of Neural Stem Cell Biology on CNS Carcinogenesis and Tumor Types
Kurian, K. M. (2011) · Pathology Research International · doi:10.4061/2011/685271 · Cited by 3
Chao, Q., Li, X., & Huang, Y. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_733_23 · Cited by 3
Pan, M., Zhou, M. Y., Jiang, C., Zhang, Z., Bui, N. Q., Bien, J. Y., Siy, A., Achacoso, N. S., Solorzano, A. V., Tse, P., et al. (2024) · BJC Reports · doi:10.1038/s44276-023-00029-3 · Cited by 3
Fang, K.-T., Su, C.-S., Layos, J. J., Lau, N. Y. S., & Cheng, K. (2024) · Cancers · doi:10.3390/cancers16051046 · Cited by 3
Genetics and Biology of Glioblastoma Multiforme
do Carmo, A., Crespo, I., & Celeste, M. G. (2011) · InTech eBooks · doi:10.5772/23479 · Cited by 3
Multimodality Targeting of Glioma Cells
He, Z., Mitteer, R. A., Mou, Y., & Fan, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47660-7.00005-7 · Cited by 3
Intratumor Heterogeneity and Transcriptional Profiling in Glioblastoma: Translational Opportunities
Piccirillo, S. G. M., & Spiteri, I. (2015) · Future Neurology · doi:10.2217/fnl.15.16 · Cited by 3
Metadata
- Authors
- Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., Stommel, J. M., Dunn, K. L., Wiedemeyer, R., You, M. J., Brennan, C., Wang, Y. A., Ligon, K. L., Wong, W. H., Chin, L., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Stanford University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2008-10
- Volume
- 455
- Issue
- 7216
- Pages
- 1129-1133
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4051433
- OpenAlex
- W2109610561
- Cited by
- 767
- References
- 37
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 32 · 2023: 41 · 2022: 33 · 2021: 32 · 2020: 41 · 2019: 33 · 2018: 35 · 2017: 38 · 2016: 39 · 2015: 46 · 2014: 47 · 2013: 61 · 2012: 76
- FWCI
- 27.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01 CA99041, R01CA099041, U01CA84313, 5P01CA95616, U01CA084313, P01CA095616)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- p53, PTEN, glioblastoma, neural stem cells, glioma stem cells, c-Myc, tumor suppressor inactivation, cell differentiation, cell renewal, TP53 mutation, PTEN mutation, gene expression profiling, promoter analysis, EGFR, neurofibromatosis type 1, RB1, ATM, APC
- MeSH terms
- Animals, Brain Neoplasms, Cell Differentiation, Gene Expression Regulation, Glioblastoma, Glioma, Humans, Immunohistochemistry, Neurons, Neoplastic Stem Cells, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review